Regulatory Work. LILLY shall be responsible for determining all regulatory responsibilities for the preparation and filing of all Drug Approval Applications in the name of LILLY and all activities necessary for such Drug Approval Applications including but not limited to the manufacture, marketing and sale of any Ribozyme Product. Any such work to be conducted by RPI under this Agreement will be fully-funded by LILLY as approved in the R&D Plan.
Appears in 4 contracts
Samples: Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc), License Agreement (Ribozyme Pharmaceuticals Inc), Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)
